These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 4206443)

  • 1. Nitroglycerin-induced reduction in the incidence of spontaneous ventricular fibrillation during coronary occlusion in dogs.
    Borer JS; Kent KM; Goldstein RE; Epstein SE
    Am J Cardiol; 1974 Apr; 33(4):517-20. PubMed ID: 4206443
    [No Abstract]   [Full Text] [Related]  

  • 2. Beneficial electrophysiologic effects of nitroglycerin during acute myocardial infarction.
    Kent KM; Smith ER; Redwood DR; Epstein SE
    Am J Cardiol; 1974 Apr; 33(4):513-6. PubMed ID: 4206442
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of nitroglycerin and nitroglycerin-methoxamine during acute myocardial ischemia in dogs with pre-existing multivessel coronary occlusive disease.
    Myers RW; Scherer JL; Goldstein RA; Goldstein RE; Kent KM; Epstein SE
    Circulation; 1975 Apr; 51(4):632-40. PubMed ID: 803882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of ischemic injury by nitroglycerin during acute myocardial infarction.
    Epstein SE; Kent KM; Goldstein RE; Borer JS; Redwood DR
    N Engl J Med; 1975 Jan; 292(1):29-35. PubMed ID: 803223
    [No Abstract]   [Full Text] [Related]  

  • 5. Electrophysiologic effects of nitroglycerin during experimental coronary occlusion.
    Levites R; Bodenheimer MM; Helfant RH
    Circulation; 1975 Dec; 52(6):1050-5. PubMed ID: 810264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of intravenous nitroglycerin on collateral blood flow and infarct size in the conscious dog.
    Jugdutt BI; Becker LC; Hutchins GM; Bulkley BH; Reid PR; Kallman CH
    Circulation; 1981 Jan; 63(1):17-28. PubMed ID: 6777074
    [No Abstract]   [Full Text] [Related]  

  • 7. Reduction in severity and extent of myocardial infarction when nitroglycerin and methoxamine are administered during coronary occlusion.
    Hirshfeld JW; Borer JS; Goldstein RE; Barrett MJ; Epstein SE
    Circulation; 1974 Feb; 49(2):291-7. PubMed ID: 4204132
    [No Abstract]   [Full Text] [Related]  

  • 8. Protection of ischemic myocardium by nitroglycerin: experimental and clinical results.
    Epstein SE; Borer JS; Kent KM; Redwood DR; Goldstein RE; Levitt B
    Circulation; 1976 Mar; 53(3 Suppl):I191-8. PubMed ID: 815059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute coronary occlusion: prolonged increase in collateral flow following brief administration of nitroglycerin and methoxamine.
    Capurro NL; Kent KM; Smith HJ; Aamodt R; Epstein SE
    Am J Cardiol; 1977 May; 39(5):679-83. PubMed ID: 404862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of nitroglycerin-methoxamine combination on infarct size in conscious dogs.
    Sheehan FH; Goldstein RE; Bolli R; Epstein SE
    Am Heart J; 1983 Jan; 105(1):37-43. PubMed ID: 6401371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary artery occlusion in the conscious dog. Effects of alterations in arterial pressure produced by nitroglycerin, hemorrhage, and alpha-adrenergic agonists on the degree of myocardial ischemia.
    Smith ER; Redwood DR; McCarron WE; Epstein SE
    Circulation; 1973 Jan; 47(1):51-7. PubMed ID: 4631342
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of nitroglycerin on the size of experimental myocardial infarction.
    Bleifeld W; Wende W; Bussmann WD; Meyer J
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 277(4):387-400. PubMed ID: 4267542
    [No Abstract]   [Full Text] [Related]  

  • 13. Modification of experimental myocardial infarct size by cardiac drugs.
    Puri PS
    Am J Cardiol; 1974 Apr; 33(4):521-8. PubMed ID: 4818050
    [No Abstract]   [Full Text] [Related]  

  • 14. Dissociation of effects of nitroglycerin on regional refractoriness and regional myocardial blood flow following acute coronary occlusion.
    Michaelson SP; Batsford WP; Zaret BL
    Cardiovasc Res; 1979 Jul; 13(7):407-12. PubMed ID: 114301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of nitroglycerin on vulnerability to ventricular fibrillation during myocardial ischemia and reperfusion.
    Stockman MB; Verrier RL; Lown B
    Am J Cardiol; 1979 Feb; 43(2):233-8. PubMed ID: 104608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experimental study of the use of magnesium and of ajmaline in ventricular bathmotropic disorders secondary to acute coronary occlusion].
    Critelli G; Cernigliaro C; Rizzo S; Santucci A; Marigliano V; Giuliano G
    Atti Soc Ital Cardiol; 1969 Jan; 2():270-81. PubMed ID: 5406542
    [No Abstract]   [Full Text] [Related]  

  • 17. Regional and global myocardial effects of intravenous and sublingual nitroglycerin treatment after experimental acute coronary occlusion.
    Lang TW; Meerbaum S; Corday E; Davidson RM; Hashimoto K; Farcot JC; Osher J
    Am J Cardiol; 1976 Mar; 37(4):523-43. PubMed ID: 816189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiologic properties of nitroglycerin in man.
    Gould L; Reddy CV; Chua W; Swamy CR; Dorismond JC
    Am Heart J; 1977 Sep; 94(3):341-8. PubMed ID: 407782
    [No Abstract]   [Full Text] [Related]  

  • 19. [Relationship between lidocaine-induced suppression of premature excitation and reduced possibility of the appearance of ventricular fibrillation in myocardial infarction].
    Wojtala M; Stopczyk M
    Kardiol Pol; 1982; 25(7-8):647-53. PubMed ID: 7169751
    [No Abstract]   [Full Text] [Related]  

  • 20. Lidocaine converts inducible ventricular fibrillation into sustained ventricular tachycardia in conscious dogs with recent myocardial infarction.
    Aidonidis I; Brachmann J; Rizos I; Toutouzas P; Kübler W
    Cardiology; 1994; 85(6):378-87. PubMed ID: 7697673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.